Elsayed A, Elsayed B, Elmarasi M, Elsabagh A, Elsayed E, Elmakaty I
Immunotargets Ther. 2024; 13:461-486.
PMID: 39290805
PMC: 11407319.
DOI: 10.2147/ITT.S463384.
Burgart Y, Elkina N, Shchegolkov E, Krasnykh O, Makhaeva G, Triandafilova G
Molecules. 2023; 28(1).
PMID: 36615256
PMC: 9821843.
DOI: 10.3390/molecules28010059.
Dahal A, Lo M, Singh S, Vo H, ElHage D, Jois S
Chem Biol Drug Des. 2022; 99(4):620-633.
PMID: 35156777
PMC: 10127554.
DOI: 10.1111/cbdd.14030.
Clemons Bankston P, Al-Horani R
Int J Mol Sci. 2019; 20(12).
PMID: 31226783
PMC: 6628068.
DOI: 10.3390/ijms20123013.
Xie F, Li B, Xiao X
Bioorg Med Chem Lett. 2017; 27(4):994-998.
PMID: 28073675
PMC: 5296214.
DOI: 10.1016/j.bmcl.2016.12.078.
Current Management of Primary Immune Thrombocytopenia.
Provan D, Newland A
Adv Ther. 2015; 32(10):875-87.
PMID: 26499177
PMC: 4635183.
DOI: 10.1007/s12325-015-0251-z.
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.
Nuhs A, De Rycker M, Manthri S, Comer E, Scherer C, Schreiber S
PLoS Negl Trop Dis. 2015; 9(9):e0004094.
PMID: 26407168
PMC: 4583543.
DOI: 10.1371/journal.pntd.0004094.
A high throughput array microscope for the mechanical characterization of biomaterials.
Cribb J, Osborne L, Hsiao J, Vicci L, Meshram A, OBrien 3rd E
Rev Sci Instrum. 2015; 86(2):023711.
PMID: 25725856
PMC: 4344474.
DOI: 10.1063/1.4907705.
β-Keto esters from ketones and ethyl chloroformate: a rapid, general, efficient synthesis of pyrazolones and their antimicrobial, in silico and in vitro cytotoxicity studies.
Ragavan R, Kumar K, Vijayakumar V, Sarveswari S, Ramaiah S, Anbarasu A
Org Med Chem Lett. 2013; 3(1):6.
PMID: 23870758
PMC: 3726461.
DOI: 10.1186/2191-2858-3-6.
The biology of thrombopoietin and thrombopoietin receptor agonists.
Kuter D
Int J Hematol. 2013; 98(1):10-23.
PMID: 23821332
DOI: 10.1007/s12185-013-1382-0.
Synthesis of oleophilic electron-rich phenylhydrazines.
Jankowiak A, Kaszynski P
Beilstein J Org Chem. 2012; 8:275-82.
PMID: 22423295
PMC: 3302090.
DOI: 10.3762/bjoc.8.29.
Antitumoral activity of allosteric inhibitors of protein kinase CK2.
Moucadel V, Prudent R, Sautel C, Teillet F, Barette C, Lafanechere L
Oncotarget. 2011; 2(12):997-1010.
PMID: 22184283
PMC: 3282105.
DOI: 10.18632/oncotarget.361.
Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.
Matthews E, Thevenin D, Rogers J, Gotow L, Lira P, Reiter L
FASEB J. 2011; 25(7):2234-44.
PMID: 21402716
PMC: 3114528.
DOI: 10.1096/fj.10-178673.
Impact of high-throughput screening in biomedical research.
Macarron R, Banks M, Bojanic D, Burns D, Cirovic D, Garyantes T
Nat Rev Drug Discov. 2011; 10(3):188-95.
PMID: 21358738
DOI: 10.1038/nrd3368.
Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.
Cook L, Cooper N
Drug Des Devel Ther. 2010; 4:139-45.
PMID: 20689640
PMC: 2915538.
DOI: 10.2147/dddt.s8601.
Biology and chemistry of thrombopoietic agents.
Kuter D
Semin Hematol. 2010; 47(3):243-8.
PMID: 20620435
PMC: 2904343.
DOI: 10.1053/j.seminhematol.2010.02.005.
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.
Metjian A, Abrams C
Biologics. 2010; 3:499-513.
PMID: 20054440
PMC: 2802075.
Thrombopoietin and platelet production in chronic immune thrombocytopenia.
Kuter D, Gernsheimer T
Hematol Oncol Clin North Am. 2009; 23(6):1193-211.
PMID: 19932428
PMC: 2789970.
DOI: 10.1016/j.hoc.2009.09.001.
Peptide immobilized on gold particles enhances cell growth.
Gong J, Ito Y
Cytotechnology. 2009; 58(3):141-4.
PMID: 19137449
PMC: 2652554.
DOI: 10.1007/s10616-008-9179-3.
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Erickson-Miller C, Delorme E, Tian S, Hopson C, Landis A, Valoret E
Stem Cells. 2008; 27(2):424-30.
PMID: 19038790
PMC: 2729672.
DOI: 10.1634/stemcells.2008-0366.